8 minute read
Auditors’ Report
Independent auditors’ report
Advertisement
Report on the Audit of the Financial Statements
We have audited the consolidated and stand-alone financial statements of Medical Disposables & Supplies Limited (“the Company”) and its subsidiaries (together the Group) which comprise the consolidated and stand-alone statement of financial position as at March 31, 2021, the consolidated and stand-alone statement of profit or loss and other comprehensive income, consolidated and stand-alone statement of changes in equity and consolidated and stand-alone statement of cash flows for the year then ended and notes to the financial statements including a summary of significant accounting policies and other explanatory information.
In our opinion, the consolidated and stand-alone financial statements give a true and fair view of the consolidated and stand-alone financial position of the Group and the Company as at March 31, 2021, and of the consolidated and stand-alone financial performance and cash flows for the year then ended in accordance with International Financial Reporting Standards (IFRS) and the Jamaican Companies Act.
Basis for Opinion We conducted our audit in accordance with International Standards on Auditing (ISAs). Our responsibilities under those standards are further described in the Auditor’s Responsibilities for the Audit of the Financial Statements section of our report. We are independent of the Group and Company in accordance with the International Ethics Standards Board for Accountants’ Code of Ethics for Professional Accountants (IESBA Code) and we have fulfilled our other ethical responsibilities in accordance with the IESBA Code. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.
Key Audit Matters Key audit matters are those matters that in our professional judgement were of most significance in our audit of the financial statements of the current period. The matter was addressed in the context of our audit of financial statements as a whole, and in forming our opinion thereon, and we do not provide a separate opinion on this matter.
(i) Business combination
Effective March 30, 2021 Cornwall Enterprises Limited (CEL), a subsidiary of Medical Disposables & Supplies Limited (MDS), acquired the assets and liabilities of Cornwall Medical and Dental Supplies Limited, whose main activities were selling and distribution of medical and dental supplies and also operated registered pharmacies. In accordance with IFRS 3, Business Combination, the transaction was deemed to be a business combination as the assets acquired and liabilities assumed constitute a business. Cornwall Enterprises Limited was identified as the acquirer as prescribed by IFRS 3 qualifying factors. At the acquisition date, the amounts of the identifiable assets acquired and liabilities assumed, are measured at fair value.
hlbjm.com
Partners: Sixto P. Coy, Karen A. Lewis 3 Haughton Avenue, Kingston 10, Jamaica W.I. 56 Market Street, Montego Bay, Jamaica W.I. TEL: (876) 926-2020/2 TEL: (876) 926-9400 TEL: (876) 952-2891 EMAIL: info@hlbjm.com
2021 Annual Report - Medical Disposables & Supplies Limited - Auduted Financial Statements
Independent auditors’ report (cont’d)
Report on the Audit of the Financial Statements (cont’d)
Key Audit Matters (cont’d) (i) Business combination (cont’d)
Management obtained an independent valuation of the intangible assets in connection with certain assets acquired from Cornwall Medical and Dental Supplies Limited for financial reporting purpose.
Management judgement was applied as follows: • In identifying and estimating the fair value of certain assets acquired as part of the transaction. • In determining the likely economic lifespan of the assets acquired, based on consideration of similar assets.
How our audit addressed the key audit matter
Our audit procedures included, amongst others:
Company in arriving at the fair value of the assets acquired. • Assessed the adequacy of the disclosures in the financial statements. • We tested the Group ownership in shares in CEL.
Based on the procedures performed, we concluded that management’s valuation is reasonable. (ii) Allowance for expected credit losses
As at March 31, 2021 trade and other receivables after allowance for expected credit losses amounted to $457,387,463 or 19.97% of the total assets. We consider the measurement of expected credit losses a key audit matter as the determination is based on management’s judgement and subject to significant uncertainty.
The principles for determining expected credit losses are described in the summary of significant accounting policies. The management of credit risk and the review for impairment are described in more detail in Note 27 to the financial statements.
How our audit addressed the key audit matter
Our audit procedures included, amongst others:
Company in order to assess expected credit losses. • Evaluated the information of economic parameters included in the forward-looking information. • Tested the accuracy of the ECL calculation. • Tested subsequent collection from selected overdue customer assets. • Assessed the adequacy of the disclosures in the financial statements. • Assessed and validated the inputs used and assumptions applied in determining the loss rates which are integral to the provision matrix used in determining the expected credit losses for trade receivables.
Independent auditors’ report (cont’d)
Report on the Audit of the Financial Statements (cont’d) Responsibilities of Management and Those Charged with Governance for the Consolidated and Stand-alone Financial Statements
Management is responsible for the preparation of financial statements that give a true and fair view in accordance with IFRS and the Jamaican Companies Act, and for such internal control as management determines is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error. In preparing the consolidated and stand-alone financial statements, management is responsible for assessing the Group’s and Company’s ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless management either intends to liquidate the Group or the Company or to cease operations, or has no realistic alternative but to do so.
Those charged with governance are responsible for overseeing the Group’s and Company’s financial reporting process.
Auditor’s Responsibilities for the Audit of the Consolidated and Stand-alone Financial Statements Our objectives are to obtain reasonable assurance about whether the consolidated and stand-alone financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor’s report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.
As part of an audit in accordance with ISAs, we exercise professional judgment and maintain professional skepticism throughout the audit. We also:
• Identify and assess the risks of material misstatement of the financial statements, whether due to fraud or error, design and perform audit procedures responsive to those risks, and obtain audit evidence that is sufficient and appropriate to provide a basis for our opinion. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control.
• Obtain an understanding of internal control relevant to the audit in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Group’s and Company’s internal control.
• Evaluate the appropriateness of accounting policies used and the reasonableness of accounting estimates and related disclosures made by management.
2021 Annual Report - Medical Disposables & Supplies Limited - Auduted Financial Statements
Independent auditors’ report (cont’d)
Report on the Audit of the Financial Statements (cont’d)
Auditor’s Responsibilities for the Audit of the Consolidated and Stand-alone Financial Statements (cont’d) • Conclude on the appropriateness of management’s use of the going concern basis of accounting and, based on the audit evidence obtained, whether a material uncertainty exists related to events or conditions that may cast significant doubt on the Group’s or Company’s ability to continue as a going concern. If we conclude that a material uncertainty exists, we are required to draw attention in our auditor’s report to the related disclosures in the consolidated and stand-alone financial statements or, if such disclosures are inadequate, to modify our opinion. Our conclusions are based on the audit evidence obtained up to the date of our auditor’s report. However, future events or conditions may cause the Group or Company to cease to continue as a going concern.
• Evaluate the overall presentation, structure and content of the consolidated and stand-alone financial statements, including the disclosures, and whether the consolidated and stand-alone financial statements represent the underlying transactions and events in a manner that presents a true and fair view.
• Obtain sufficient appropriate audit evidence regarding the financial information of the entities or business activities within the Group and Company to express an opinion on the consolidated and stand-alone financial statements. We are responsible for the direction, supervision and performance of the audit. We remain solely responsible for our audit opinion.
We communicate with the Board of Directors regarding, among other matters, the planned scope and timing of the audit and significant audit findings, including any significant deficiencies in internal control that we identify during our audit.
Report on additional matters as required by the Jamaican Companies Act We have obtained all the information and explanations which, to the best of our knowledge and belief, were necessary for the purposes of our audit. In our opinion, proper accounting records have been maintained, so far as appears from our examination of those records, and the financial statements, which are in agreement therewith, give the information required by the Jamaican Companies Act, in the manner required.
The Engagement Partner on the audit resulting in this independent auditor’s report is Sixto P. Coy.
Kingston, Jamaica July 8, 2021 Chartered Accountants
